Introduction
Since Parodi reported the first successful endovascular aneurysm repair procedure in 1991, this procedure has gained wide acceptance for the treatment of abdominal aortic aneurysms in the past two decades. This minimally invasive approach has been proven effective and safe in the treatment of abdominal aortic aneurysm patients with lower early morbidity and mortality rates compared to open surgery repair. Meanwhile, dozens of endografts have been designed for endovascular aneurysm repair, and most of them are now still undergoing modification and improvement. Although these devices have been improved over time, secondary procedures are required in up to 27% of patients following endovascular aneurysm repair. Complications of stent-graft migration, endoleaks, stent rupture/fracture, aortic neck dilatation and development of other aortoiliac aneurysms mandate lifelong patient follow-up. Among these complications the most prevalent and concerning complications are distal migration (defined by the Society for Vascular Surgery as device movement of greater than 10 mm or lesser device movement necessitating secondary intervention) and Type I endoleak, putting the patients under an increasing risk of aneurysm rupture. Migration has a reported incidence of up to 45%, and has been shown in biomechanical analyses to be the result of both persistent downward flow upon the stent-graft bifurcation (affecting neck fixation), and transverse forces, resulting in device lateral movement (affecting neck fixation, component stability, and iliac fixation). Type I endoleak is closely associated with migration, and is certainly the most significant predictor of aneurysm increase, risk of rupture, and need for secondary intervention or open conversion repair. Therefore, the most favorable design of endovascular aneurysm repair endograft should theoretically support to counteract the downward force of pulsatile blood flow and possibly prevent distal migration. Now on the market most of the endovascular aneurysm repair endografts are modular devices and deployed from proximal to distal. The Endologix (Irvine, CA, USA) Powerlink R device is the only unibody endograft which is deployed at the aortic bifurcation ("anatomical fixation"). From our nearly 16 years experience of more than 1700 (ending in November 2009) endovascular aneurysm repair cases with 13 different endografts, we prefer the Powerlink R unibody bifurcated device for this challenge. Ending in December 2008, 612 cases of endovascular aneurysm repair were performed using the Powerlink R device in our single center, in 513 patients the devices were implanted "anatomically" from the aortoiliac bifurcation to the renal artery level with or without proximal cuff and/or additional Palmaz R stent. We have published our outcomes with the Powerlink R for abdominal aortic aneurysms in the last years. In one article, the results included the cases that deployed not "anatomically". The objective of this report is to summarize our 12-year experience of endovascular aneurysm repair for abdominal aortic aneurysm with the Powerlink R stent-graft deployed "anatomically".
Methods

Patient sample
From February 1999 to December 2008, 612 patients with infrarenal abdominal aortic aneurysm were evaluated for endovascular aneurysm repair treatment with the Endologix Powerlink R endograft in our center. Of this cohort in 513 patients the devices were implanted "anatomically" from the aortoiliac bifurcation to the renal artery level with or without proximal cuff and/or additional Palmaz R stent. According to the American Society of Anesthesiologists' physical status classification there were 60.8% (312/513) cases in ASA III/IV stage. The follow-up imaging was performed at 1 month, 6 months and yearly thereafter. Computed tomography angiograms with a 2.5-mm slice thickness were routinely performed to determine endovascular aneurysm repair eligibility. Data of these 513 patients were retrospectively analyzed in the study. Of these 513 patients, a special analysis was also made of data from 117 cases with short and/or angulated necks (from February 1999 to December 2007) (Table 1) Figure 1 ). Accessory limb extensions in straight, stepped, flared, and tapered configurations are available to permit customization to patient anatomy as needed ( Figure 2 ). Device availability permits the treatment of patients with proximal aortic neck diameters of 18 to 32 mm, and distal iliac seal zone diameters of 10 to 23 mm. The low profile 19 Fr delivery system introducer requires only one surgically exposed femoral artery for deployment. Unique to this device, contralateral access is obtained percutaneously (9Fr) through a precannulated contralateral limb. These features enable use of the device in patients with one small or severely diseased iliac access vessel, where with available proximal fixation devices, this is not possible. The Powerlink R design and access flexibility thus increase the number of patients that can be electively treated by endovascular aneurysm repair. Moreover, the use of the integrated introducer sheath for accessory delivery and deployment and ancillary device introduction reduces the need for exchanges, thereby minimizing the potential for vessel intimal injury (Figure 3 ). 
EVAR procedure with the Powerlink R system
Stent-graft selection is based on pre-operative and intra-operative measurements of aortic non-aneurysmal neck diameter, aortic length from the most caudal renal artery to the aortic bifurcation, and length from the aortic bifurcation to the hypogastric arteries. Procedures are performed in suitably equipped operating rooms or endovascular suites with operating room availability. Proper fluoroscopic imaging equipment and tools include a mobile Carm, automated contrast injector, intraoperative angiography, and if preferred, intravascular ultrasound. Bifurcated and, as needed, proximal extension stent-graft models are chosen per established sizing algorithms, while achieving proximal seal and fully lining the infrarenal aorta. After angiography and aortic length verification with a marker catheter, the bifurcated stent graft delivery system contralateral guidewire is placed, and the integrated 19Fr introducer sheath is advanced over the stiff guidewire into the aorta. Under fluoroscopic visualization, the introducer sheath is retracted to expose the constrained bifurcated stent graft. The constrained device is then placed upon the aortoiliac bifurcation, after which the main body and each limb of the device are deployed using a simple yet metered control cord mechanism. This results in implantation of the device at the aortoiliac bifurcation (i.e., anatomical fixation). Based on the patient anatomy and intraoperative angiography, an accessory proximal extension is placed as needed to achieve adequate overlap with the bifurcated device and seal in the proximal neck ( Figure 4 ). Limb extensions can similarly be placed as needed to accommodate patient anatomical needs. Balloon dilatation may be performed if desired. 2.4 Palmaz R stent and deployment procedure Palmaz R stents are inserted through a 14-F Check-Flo Performer introducer (Cook, Bloomington, IN, USA) . The stent can be expanded to 14-25 mm correspondingly the length from 37.79-30.58 mm. The stent was advanced and deployed across the renal arteries and top of the graft with a MAXI LD PTA balloon dilation catheter (Cordis, Miami, FL, USA). We usually choose a P4014 Palmaz R stent, a 25mm-diameter expandable balloon and a 45cm-long 14F sheath ( Figure 5 ). The balloon had better be inflated one time whose surface is relatively coarse to prevent the stent from dislocation in the course of deployment. The Palmaz R stent was asymmetrically hand-crimped on an expandable balloon that ensures that the proximal (cranial) aspect will expand first. A long sheath is placed distal to the target area. We regularly deploy the Palmaz R stent with one third above the renal artery, since when we dilate the Palmaz R stent, it shortens. Once the balloon and stent assembly is in position, the sheath is partially retracted to allow only the proximal (cranial) half of the balloon to expand, flaring the unsheathed proximal stent. The expanded proximal balloon prevents cranial stent migration. The sheath prevents distal (caudal) stent migration. Full retraction of the sheath allows the distal balloon and stent to expand, completing the stent deployment ( Figure 6 ). 
Follow-up
All patients were evaluated before discharge; at 1 and 6 months; and annually thereafter to assess clinical symptoms, potential endoleaks, and aneurysm size. Computed tomography angiogram was performed at each visit; digital subtract angiography was used selectively in special cases, such as visible endoleak or aneurysm sac enlargement seen on computed tomography angiograms.
Results
This study cohort included 513 consecutive patients (mean age 72.9±8.0 years, male 461); the mean maximal aneurysm diameter was 54.6±8.9 mm. 86 (16.8%) cases underwent preliminary hypogastric embolisation in the presence of common iliac artery and/or hypogastric artery aneurysm or a too short common iliac artery. The technical success rate was 98.4% (505/513), emergent open conversion occurred in 8 cases (1.6%) because of delivery access problem. The proximal cuff was used in 61.0% (308/505), Palmaz R stent in 20.6% (104/505), limb extension in 14.3% (72/505), retrograde iliac artery endarterectomy and femoral patchplasty in 27 (5.3%) cases, iliac-femoral graft interposition in two cases. Primary type Ia endoleak occurred in 20 cases (4.0%) and all were remedied intraoperatively by Palmaz R stent or the endoleaks were considered so minimal that spontaneous vanish would be expected in close follow-up. 18 (3.5%) cases had type II endoleak and were under routine observation. Mean procedure time was 55±21 min. The 30-day mortality rate was 0.4% (2/513) ( Table 2 . Procedure details and perioperative complications 503 cases were followed up for mean 5.2 years (range, 2 months-9.5 years). Proximal type I endoleak existed in 6 cases (1.2%), all of them were primary type Ia endoleaks, 4 were revised with proximal cuff and/or Palmaz R stent and 2 by selective open conversion. Type II endoleak existed in 22 cases (4.4%), limb occlusion rate was 1.0% (5/503), partial renal infarction occurred in 9 cases (1.8%) and selective open conversion rate was 1.6% (8/503). There were no aneurysms rupture, no device migration, no type III/IV endoleak and stentgraft rupture/fracture. A reduction in mean aneurysm sac diameters and volumes has been noted at every follow-up interval (Table 3) .
Of the 117 patients with short and/or angulated neck, the technical success rate was 97.4% (114/117). Intraoperative complications included 3 (2.6%) emergent open conversions due to delivery access problem, 6 (5.3%) primary type Ia endoleaks and 5 (4.4%) type II endoleaks. The 30-day mortality was 1.7% (2/117) ( Table 2 , 4). The 2.6-year follow-up results showed 4 (3.6%) primary type Ia endoleaks, which were revised with proximal cuff and/or Palmaz R stent. Limb occlusion occurred in 2 (1.8%) cases.
There were no open conversion, no aneurysm rupture, no device migration, no type III/IV endoleaks and stent-graft rupture/fracture ( 
Discussions
The applicability of endovascular aneurysm repair in abdominal aortic aneurysms mainly depends on the aortoiliac anatomy and morphology. Among all the challenging factors limiting application of this minimally invasive technique, the infrarenal aortic aneurysm neck morphology is still the most important determinant. The infrarenal neck length and angulation are the first parameters we should consider in the indication for endovascular aneurysm repair. Some clinical studies have made it clear that abdominal aortic aneurysms with short and/or angulated necks for endovascular aneurysm repair have a high risk of stent-graft distal migration and proximal type I endoleak, which make up the exact criteria in challenging cases.
In one EUROSTAR study, 5183 patients underwent endovascular aneurysm repair from October 1996 to January 2006. Incidence of stent-graft migration, proximal type I endoleak, proximal neck dilatation, secondary interventions, aneurysm rupture, and all-cause and aneurysm-related mortality were compared between patients with and without severe infrarenal neck angulation (> 60 degrees angle between the infrarenal aortic neck and the longitudinal axis of the aneurysm). In the short term (before discharge), stent-graft migration (OR 2.17, 95% CI 1.20 to 3.91, p=0.0105) and proximal type I endoleak (OR 2.32, 95% CI 1.60 to 3.37, p<0.0001) were observed more frequently i n p a t i e n t s w i t h s e v e r e i n f r a r e n a l n e c k angulation. Over the long term, proximal type I endoleak (HR 1.80, 95% CI 1.25 to 2.58, p=0.0016), higher incidences of proximal neck dilatation (> or =4 mm) (HR 1.26, 95% CI 1.11 to 1.43, p=0.0004) and need for secondary interventions (HR 1.29, 95% CI 1.00 to 1.67, p=0.0488) were seen in the severe infrarenal neck angulation group. All-cause mortality, rupture of the aneurysm and aneurysm-related mortality were similar in patients with and without severe infrarenal neck angulation. In the subgroup of patients with an Excluder endograft, proximal endoleak at the completion angiogram (OR 4.49, 95% CI 1.31 to 15.32, p=0.0166) and long-term proximal neck dilatation (HR 1.67, 95% CI 1.20 to 2.33, p=0.0026) were more frequently observed in patients with severe infrarenal neck angulation. The endovascular aneurysm repair mechanism is to construct an endoluminal exclusion channel inside the native aortoiliac artery to exclude the aneurysm from the dynamic blood flow to prevent rupture, and the endoluminal exclusion channel must be stable and sealed. But short necks are unable to provide sufficient proximal landing zone for secure fixation and seal; angulated necks are unable to provide proper anchoring adaptation for secure fixation and seal. Is there an optimal device to adapt to these challenging anatomies? Most of the authors and the currently available devices emphasize the proximal fixation with bars/hooks/crimps and suprarenal fixation, but device distal migration is still unavoidable. Interestingly, all the currently available modular devices were designed to implant starting just below the renal arteries, which will result in hanging the device inside the aneurysm sac. From the dynamic mechanism, it is not stable, as the blood flow through the stent-graft acts as a displacing force, and the endograft is normally held in position by friction dependant on the radial force of the graft against the aortic wall and the contact surface between the graft material and the artery wall. Completely contrary to these modular devices, the Powerlink R one-piece long main body bifurcated stent-graft was designed to be implanted sitting on the native abdominal aortic bifurcation. We have termed this technique "Anatomical Fixation", which proved effective in eradicating distal migration. Mimicking construction of a building, the endoluminal exclusion channel can be built up to the renal artery level with an oversized long suprarenal proximal cuff. After endograft stability has been achieved, more attention should be paid to the proximal fixation and seal. A compulsory ballooning of the neck and the conjunction part was routinely carried out for better adaptation. Palmaz R stent implantation depends on the angiogram outcome. We normally implant the Palmaz R stent only if there is a high risk of proximal type I endoleak. A Palmaz R stent is used in the neck to strengthen the radial fixation force and to adapt the graft to the aortic wall for better seal. Balloon-expandable Palmaz R stent has been proven to provide better seal as well as fixation in treating hostile necks. After building upon the foundation of the bifurcated endograft, a suprarenal proximal cuff with a long overlapping segment inside the bifurcated main body endograft is built up to the renal artery level. In our whole group, proximal long cuff was used in 61.0% (308/505) cases, and in the hostile neck group, all the patients had the proximal long cuff. This long cuff is not only used for prevention of type III endoleak but also useful for stretching the angulated segment of the infrarenal aorta, namely remodeling and straightening the proximal angulated neck. 20.6% (104/505) and 72.8% (83/114) patients had proximal Palmaz R stents in the whole group and the hostile neck group, respectively, resulting in further remodeling of the infrarenal aorta with more contact area for better fixation and seal (Figure 7) . Regarding the device size choice, the Powerlink R unibody bifurcated stent-graft is different from the modular devices. The distance from the lowest renal artery to the abdominal aortic bifurcation, and the distance from the aortic bifurcation to the hypogastric artery are important parameters for the size choice. Graft length is determined by the lengths of the native abdominal aorta and the common iliac artery. Graft diameter is determined by oversizing the endograft by 10-20% in excess of the measured neck diameter. Due to the several standard sizes of the main body, proximal cuff and limb extension, this system proved simple and easy for size selection. The most commonly used main body size in our unit is 25 mm in neck diameter, 10 cm in main body length, 16 mm in limb diameter, and 5.5 cm in limb length. The most commonly used suprarenal proximal cuff is 28 mm in diameter and 75 mm or 95 mm in length. studies reported that common iliac artery aneurysms exist in about 20% to 30% of patients with abdominal aortic aneurysms who were examined for endovascular aneurysm repair. In our study, the applicability of endovascular aneurysm repair was increased by 16.8% (86/513) after preliminary hypogastric aneurysm embolization. Therefore, preliminary embolization of hypogastric artery with additional extension of the graft to the external iliac artery may expand the indication of endovascular aneurysm repair. But we all know that hypogastric artery embolization will cause pelvic ischemic complications such as buttock claudication, sexual dysfunction and other pelvic ischemia symptoms (e.g., gluteal necrosis, spinal cord ischemia, rectosigmoid ischemia, or limb ischemia). In our center, a retrospective review was conducted of all 101 consecutive patients (91 men; mean age 73.4 ± 8.7 years) who underwent preliminary embolization of 133 hypogastric arteries about 4 to 6 weeks prior to endovascular aneurysm repair from January 2005 to August 2009. Fourteen patients with 19 hypogastric arteries were treated using coils, while 87 patients were treated with Amplatzer Vascular Plugs in 114 hypogastric arteries. In the coil group, complete occlusion was achieved in 16 (84.2%) of 19 procedures. There were no acute pelvic ischemic symptoms after hypogastric artery embolization or endovascular aneurysm repair. Five (35.7%) patients had buttock claudication and 2 (16.7%) of 12 men experienced new erectile dysfunction after embolization. At a mean 42.2-month follow-up (range 14-58), 3 (21.4%) patients had a type II endoleak via retrograde flow in the hypogastric artery without aneurysm growth and were under observation. In the Amplatzer Vascular Plugs group, all 114 hypogastric arteries in 87 patients were successfully occluded; there was no device dislodgment or limb ischemia observed. Buttock claudication and new sexual dysfunction developed in 12 (13.8%) patients and 4 (5.1%) of 79 men after the procedure, respectively. During a mean 26.4-month follow-up (range 4-54), 2 (2.3%) patients developed distal type I endoleaks after endovascular aneurysm repair, but angiography confirmed that neither of the endoleaks was related to the vessel embolized with the Amplatzer Vascular Plugs. Comparing the outcomes of the treatment groups, the Amplatzer Vascular Plugs was placed with fewer intraoperative complications (p=0.013) and more complete occlusion (p=0.01) than coil embolization. The rate of buttock claudication was lower in the Amplatzer Vascular Plugs group (p=0.042). Our clinical researches showed that hypogastric aneurysm embolization prior to endovascular aneurysm repair is safe and effective. The Amplatzer R Vascular Plug affords easier and more precise placement and provides more complete occlusion, with fewer intraoperative and postoperative ischemic complications than coil embolization. For proximal type I endoleak, balloon angioplasty is first recommended in our experience. If it does not work, a Palmaz R stent in the aneurysm neck is able to cure the endoleak. There were 20 cases and 6 cases of primary proximal type I endoleaks in the whole group and the short and/or angulated neck group after balloon angioplasty, respectively. But after the deployment of the palmaz R stent, all of them were remedied or minimal that spontaneous vanish was expected by operators in the follow-up. During the mid-term or long-term follow-up, only 6 and 4 primary proximal type I endoleak still existed in the two groups. If there is still some space between the renal artery and the top of the stent-graft, a suprarenal proximal cuff with or without Palmaz R stent can achieve a good result. Only 2 cases in the whole group underwent selective open conversion, the other 4 were all remedied by endovascular re-intervention. Delivery access problems were the main reasons for emergent open conversion. In our study, all of the intraoperative emergent open conversion occurred because of the delivery access problems. But with the accumulation of our experience, for most stenotic iliac arteries, pre-dilatation with an 8 mm or 10 mm angioplasty balloon can usually solve the problem. If not, we preferred retrograde iliac artery endarterectomy with Moll Ring cutter. 9 (1.8%) cases in the whole group suffered from partial renal infarction found on computed tomography scan, but the renal function was not impaired. Though all these 9 cases had suprarenal fixation, a controlled study from two pivotal US Food and Drug Administration trials using the Powerlink R bifurcated stent-graft revealed that suprarenal fixation does not lead to a significant increase in acute renal events, renal impairment, or alteration in blood pressure compared with infrarenal fixation. During the trials, 283 patients underwent endovascular aneurysm repair with the Powerlink R bifurcated stent-graft. A comparison of preoperative, perioperative (1 ~ 7 days), and postoperative (>7 days) alterations in serum creatinine, creatinine clearance and blood pressure was done. Renal adverse events were determined by computed tomography scan and clinical chart review and included renal infarction, renal artery stenosis (either progressive or requiring renal stent placement) and renal artery occlusion. Both suprarenal fixation and infrarenal fixation groups showed a significant increase in serum creatinine and a decrease in creatinine clearance over time. No significant difference in serum creatinine or creatinine clearance existed between groups during any time period. There were no differences in postoperative renal impairment (infrarenal, 10.2%; suprarenal, 7.6%, P = 0.634), the need for hemodialysis (infrarenal, 0.7%; suprarenal, 0%, P = 1.00), systolic and diastolic blood pressure during subsequent follow-up between treatment groups. There was no significant difference in the number of renal adverse events detected by computed tomography between the infrarenal fixation (10, 6.8%) group and the suprarenal fixation (3, 3.8%) group (P = 0.550). Proximal fixation devices artificially elevate the aortoiliac bifurcation, requiring contralateral limb cannulation some distance from the patient's native aortoiliac bifurcation. In the case of a narrow distal aorta, bi-lobe or saccular aneurysms, such maneuvers can be challenging or unachievable. An example of this is highlighted in a recent report regarding a newer device, where the distal aortic diameter averaged 33mm in enrolled patients, more than 50% increased over that of patients enrolled in the Powerlink R anatomical fixation trials. Even with this large distal aortic diameter, intraoperative limb stenosis requiring stenting occurred in 11% of patients, with intervention within 30 days for limb occlusion or thrombosis performed in 2.2% of patients, leading the authors to suggest prophylactic intraoperative limb stenting. It is not known if the long-term rate of limb kinking/occlusion will be similar to the 4.3% rate reported for other currently available devices. Interestingly, endografts with fully supported limbs (e.g., Excluder, Powerlink R ) appear to have greater resistance to intraoperative stenosis and kinking and the lowest reported rates of limb kinking or occlusion with long-term follow-up (1.7%, 1.2%). Because the Powerlink R device includes a pre-cannulated contralateral limb requiring only 9Fr percutaneous access, anatomical fixation implantation eliminates the cannulation problem. In a multinational registry analysis of patients presenting with coronary artery disease, cerebrovascular disease, or peripheral arterial disease, patients with abdominal aortic aneurysms were found to have a three-fold increased incidence of peripheral artery disease than those without abdominal aortic aneurysms. One cannot deny that preserving the native aortoiliac bifurcation after endovascular aneurysm repair to enable future peripheral interventions is an important consideration. aorta and may involve the aortoiliac vasculature. A subset of infrarenal aneurysms extend up to the level of but do not involve the renal arteries (juxtarenal aneurysms) or extend further to involve one or both of the renal arteries (pararenal aneurysms). As noted previously, a substantial proportion of infrarenal aneurysms are not suitable for endovascular aneurysm repair due to unfavorable proximal neck anatomy (e.g., severely angulated, dilated, short, or encroaching on or involving the renal arteries). In regulatory studies of infrarenal endovascular aneurysm repair, patients were carefully selected to ensure neck length and angulation requirements were met in order to optimize outcomes. Shorter length or greater angulation has been reported since the original trials to increase the risk of migration and Type Ia endoleak and associated with need for intervention.
Owing to the increased risk of renal complications, mesenteric ischemia and other complications following open repair of juxtarenal or pararenal aneurysms compared to infrarenal aneurysms, researchers have sought to extend a totally endovascular technique to repair these aneurysms. In this treatment, it is essential to maintain the patency of the renal arteries and other visceral vessels. Up to now, only homemade or customized fenestrated stent-grafts with the use of commercially available uncovered or covered vascular stents have been used for the repair of juxtarenal aneurysms. The key limitation to this approach is the need to customize the design and manufacture of each stent-graft to a particular patient anatomy. This requires a lengthy period of time for planning, manufacture, and delivery of the device, and is very costly. As a result, physicians have begun to seek other options, such as hybrid debranching techniques or chimney techniques. However, these options remain suboptimal. The concept of an off the shelf alternative to customization has been postulated; however this has yet to be realized. More recently, an off-the-shelf fenestrated stent-graft system has been developed based on the Powerlink R stent-graft. Integral to this system is the bifurcated stent-graft, anatomically fixed at the aortoiliac bifurcation, a fenestrated proximal extension with proprietary design, and compatible covered renal stents. All devices are constructed from cobalt chromium alloy for exceptional durability, and have a high density ePTFE covering. Initial estimates suggest this system will be applicable to 80% or more of patients with juxtarenal or pararenal aneurysm, without need for customization. Initial clinical experience will be available by the end of this year. Multicenter clinical trials are expected to commence in 2011, and if successful, would significantly increase the numbers of patients who could be treated endovascularly, would significantly reduce the time from diagnosis to treatment, and would represent significant improvement in cost effectiveness over the currently available options. The field of endovascular aneurysm repair for abdominal aortic aneurysm has matured in recent years and is progressing into ever more challenging anatomy than treated in early trials. The problems of distal migration or endoleak remain, particularly in the more challenging anatomies. Clearly utilization of the native aortoiliac bifurcation as a strong foundation on which to place the Powerlink R bifurcated stent-graft followed by achievement of proximal seal with an aortic extension if needed is a simple yet elegant way of mitigating the risk of migration and endograft destabilization. The emergence of anatomical fixation with the availability of a well designed off the shelf proximal extension and visceral branch grafts, starting clinical evaluation at this time, has strong potential to not only address a significant unmet clinical need, but to address global demands for cost-effective options for these patients. Furthermore, the prospective clinical validation of a totally percutaneous approach to endovascular aneurysm repair will serve to advance this technique and its use in properly selected patients. Other proximal fixation devices are in development or available in some regions that feature lower profile delivery systems and enhanced proximal fixation attachment mechanisms. A novel sac anchoring endovascular prosthesis (the Nellix device) is in final stages of regulatory review in Europe. This technology obliterates the aneurysm sac with a polymer-filled endobag and paving endoframe lumens. Although it has the potential to significantly reduce or eliminate the incidence of any endoleak, and thus reduce the surveillance necessary with other endovascular prostheses. Broader and longer term study will be necessary to validate this fully. The next horizon yet to be addressed is the thoracic aorta, particularly the ascending aorta, where no adequate endovascular options yet exist. Although in final proprietary development at this time, a novel endografting approach utilizing a thoracic anatomical fixation technique with in situ fenestration and branch preservation is on the future horizon.
Conclusions
Our experience demonstrated that building up the endovascular exclusion system in the abdominal aortic aneurysms using the unibody Powerlink R d e v i c e w i t h p r o x i m a l c u f f and/or additional Palmaz R stent showed a satisfactory long-term outcome, even proved safe and effective in treating abdominal aortic aneurysms with short and/or angulated neck. With this intuitive approach, stent graft migration and its related potential complications are virtually eliminated. However, prospective longer follow-up in multicenter randomized controlled larger series are necessary to confirm these encouraging outcomes.
